Caisse de Depot et Placement du Quebec (CDPQ)’s Royalty Pharma RPRX Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.3M	Buy	1,003,953 +785,922	+360%	+$40.9M	0.08%	265
2026 Q1	$10.5M	Sell	218,031 -693,654	-76%	-$30.4M	0.02%	429
2025 Q4	$35.2M	Buy	911,685 +643,985	+241%	+$24.6M	0.06%	292
2025 Q3	$9.44M	Buy	267,700 +189,373	+242%	+$6.86M	0.02%	396
2025 Q2	$2.82M	Sell	78,327 -653,074	-89%	-$21.6M	0.01%	432
2025 Q1	$22.8M	Buy	731,401 +18,616	+3%	+$590K	0.05%	300
2024 Q4	$18.2M	Buy	+712,785	New	+$18.9M	0.04%	298
2024 Q2	–	Sell	-92,452	Closed	-$2.81M	–	534
2024 Q1	$2.81M	Buy	+92,452	New	+$2.73M	0.01%	410
2023 Q2	–	Sell	-71,400	Closed	-$2.57M	–	540
2023 Q1	$2.57M	Buy	+71,400	New	+$2.65M	0.01%	446
2021 Q2	–	Sell	-18,989	Closed	-$828K	–	674
2021 Q1	$828K	Buy	+18,989	New	+$900K	﹤0.01%	567

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s RPRX Position: Q2 2026 in Review

Caisse de Depot et Placement du Quebec (CDPQ) increased its Royalty Pharma (RPRX) stake by 360% in Q2 2026, buying an estimated $40.9M and bringing the position to 1,003,953 shares worth $56.3M. The position accounts for 0.08% of the portfolio, ranked #265.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in RPRX in Q1 2021 and has held it in 10 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Caisse de Depot et Placement du Quebec (CDPQ) held 1,003,953 shares of Royalty Pharma worth $56.3M as of Q2 2026.
Caisse de Depot et Placement du Quebec (CDPQ) bought 785,922 Royalty Pharma shares in Q2 2026, an estimated $40.9M.
Royalty Pharma made up 0.08% of Caisse de Depot et Placement du Quebec (CDPQ)'s portfolio in Q2 2026, its #265 holding.
Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Royalty Pharma in Q1 2021 and has held it in 10 quarters since.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q2 2026, filed 14 Aug 2026.